All Stories

  1. Reference Standard for Validation of Age-Related Macular Degeneration Screening Algorithms
  2. Reduction in Pigment Epithelial Detachment Thickness with Faricimab vs Aflibercept 2 mg During Head-to-Head Dosing in TENAYA/LUCERNE
  3. ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR STAGES 3 AND 4 PROLIFERATIVE SICKLE CELL RETINOPATHY RESULTS IN IMPROVED ANATOMICAL AND VISUAL OUTCOMES
  4. LONGITUDINAL OUTCOMES STUDY OF SUTURELESS SCLERAL-FIXATED INTRAOCULAR LENSES
  5. Anatomic Control with Faricimab versus Aflibercept in the YOSEMITE/RHINE Trials in Diabetic Macular Edema
  6. Response of Diabetic Macular Edema to Anti-VEGF Medications Correlates with Improvement in Macular Vessel Architecture Measured with OCT Angiography
  7. Ocular and Systemic Risk Factors for Disease Worsening Among Patients with NPDR
  8. The 0.19-mg Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema
  9. METformin FOR the MINimization of Geographic Atrophy Progression (METforMIN) – A Randomized Trial
  10. Federated Learning in Diagnosing Age-Related Macular Degeneration
  11. Optimizing the OCTA layer fusion option for deep learning classification of diabetic retinopathy
  12. Federated Learning for Diagnosis of Age-related Macular Degeneration
  13. COMPARATIVE ANALYSIS OF OCT AND OCT ANGIOGRAPHY CHARACTERISTICS IN EARLY DIABETIC RETINOPATHY
  14. Contrastive learning-based pretraining improves representation and transferability of diabetic retinopathy classification models
  15. Normalized Blood Flow Index in Optical Coherence Tomography Angiography Provides a Sensitive Biomarker of Early Diabetic Retinopathy
  16. Multi-fusion strategies for deep learning artery and vein segmentation in OCT angiography
  17. Comparison of AI and dilated eye exams for the detection of diabetic retinopathy
  18. Simulation of long-term impact of intravitreal anti-VEGF therapy on patients with severe non-proliferative diabetic retinopathy
  19. Visual Field Abnormalities in Early-Stage Diabetic Retinopathy Assessed by Chromatic Perimetry
  20. Rhegmatogenous retinal detachment surgery: A review
  21. Automated Region of Interest Selection Improves Deep Learning-Based Segmentation of Hyper-Reflective Foci in Optical Coherence Tomography Images
  22. AVA-Net: an open-source deep learning network for arterial-venous area segmentation in OCT angiography
  23. Contrastive learning-based pretraining improves representation and transferability of diabetic retinopathy classification models
  24. MF-AV-Net: an open-source deep learning network with multimodal fusion options for artery-vein segmentation in OCT angiography
  25. QUANTITATIVE OPTICAL COHERENCE TOMOGRAPHY REVEALS ROD PHOTORECEPTOR DEGENERATION in EARLY DIABETIC RETINOPATHY
  26. From Data to Deployment
  27. Comparative feature analysis in OCT and OCT angiography of diabetic retinopathy
  28. Quantitative features for objective assessment of OCT angiography
  29. Pivotal Evaluation of an Artificial Intelligence System for Autonomous Detection of Referrable and Vision-Threatening Diabetic Retinopathy
  30. Imaging and artificial intelligence for progression of age-related macular degeneration
  31. Bilateral Macular Schisis in a Woman
  32. Probabilistic Forecasting of Anti-VEGF Treatment Frequency in Neovascular Age-Related Macular Degeneration
  33. Closure of Full-Thickness Macular Holes Associated with Macular Edema with Medical Therapy
  34. Prevention of Severe Nonproliferative Diabetic Retinopathy Progression With More at Stake Than Visual Acuity
  35. Deep learning artery-vein classification in OCT angiography
  36. Longitudinal Assessment of Retinal Thinning in Adults With and Without Sickle Cell Retinopathy Using Spectral-Domain Optical Coherence Tomography
  37. Sickle Cell Retinopathy
  38. AV-Net: deep learning for fully automated artery-vein classification in optical coherence tomography angiography
  39. Reply
  40. Transfer Learning for Automated OCTA Detection of Diabetic Retinopathy
  41. VASCULAR COMPLEXITY ANALYSIS IN OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF DIABETIC RETINOPATHY
  42. Quantitative analysis of vascular complexity in OCTA of diabetic retinopathy
  43. Deep learning for objective OCTA detection of diabetic retinopathy
  44. Retinal Vein Occlusions Preferred Practice Pattern®
  45. Idiopathic Macular Hole Preferred Practice Pattern®
  46. Retinal and Ophthalmic Artery Occlusions Preferred Practice Pattern®
  47. Idiopathic Epiretinal Membrane and Vitreomacular Traction Preferred Practice Pattern®
  48. ADVERSE EVENTS OF THE ARGUS II RETINAL PROSTHESIS
  49. QUANTITATIVE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY FEATURES FOR OBJECTIVE CLASSIFICATION AND STAGING OF DIABETIC RETINOPATHY
  50. Diabetic Retinopathy Preferred Practice Pattern®
  51. Age-Related Macular Degeneration Preferred Practice Pattern®
  52. Posterior Vitreous Detachment, Retinal Breaks, and Lattice Degeneration Preferred Practice Pattern®
  53. “Iodine Allergy” and the Use of Povidone Iodine for Endophthalmitis Prophylaxis
  54. AMPLITUDE LOSS OF THE HIGH-FREQUENCY FLICKER ELECTRORETINOGRAM IN EARLY DIABETIC RETINOPATHY
  55. Relating retinal blood flow and vessel morphology in sickle cell retinopathy
  56. Contrast sensitivity is associated with outer‐retina thickness in early‐stage diabetic retinopathy
  57. Hypotony and the Argus II retinal prosthesis: causes, prevention and management
  58. Simulating vascular leakage on optical coherence tomography angiography using an overlay technique with corresponding thickness maps
  59. Supervised Machine Learning Based Multi-Task Artificial Intelligence Classification of Retinopathies
  60. Longitudinal Study of Peripapillary Thinning in Sickle Cell Hemoglobinopathies
  61. Bilateral Blurry Vision in a Human Leukocyte Antigen B27–Positive Man
  62. Electrophysiological and pupillometric measures of inner retina function in nonproliferative diabetic retinopathy
  63. Fully automated geometric feature analysis in optical coherence tomography angiography for objective classification of diabetic retinopathy
  64. Differential Artery–Vein Analysis Improves the Performance of OCTA Staging of Sickle Cell Retinopathy
  65. OCT feature analysis guided artery-vein differentiation in OCTA
  66. Quantitative artery-vein analysis in optical coherence tomography angiography of diabetic retinopathy
  67. Management of severe retinal detachment
  68. Natural History of Drusenoid Pigment Epithelial Detachment Associated with Age-Related Macular Degeneration
  69. Diagnostic accuracy and reliability of retinal pathology using the Forus 3nethra fundus camera compared to ultra wide-field imaging
  70. Progression of Geographic Atrophy in Age-related Macular Degeneration
  71. Macular Vitelliform-Like Lesion in an Eye With Chronic Retinal Detachment
  72. Color Fundus Image Guided Artery-Vein Differentiation in Optical Coherence Tomography Angiography
  73. Association between Visual Acuity and Retinal Layer Metrics in Diabetics with and without Macular Edema
  74. COMPARISON OF VISUAL AND ANATOMICAL OUTCOMES OF EYES UNDERGOING TYPE I BOSTON KERATOPROSTHESIS WITH COMBINATION PARS PLANA VITRECTOMY WITH EYES WITHOUT COMBINATION VITRECTOMY
  75. Retinal Anatomy and Electrode Array Position in Retinitis Pigmentosa Patients After Argus II Implantation: An International Study
  76. Cyst Masquerading as Inadvertent Bleb After a Scleral-Fixated Intraocular Lens in Marfan Syndrome: A Case Report
  77. Analysis of Retinal Thinning Using Spectral-domain Optical Coherence Tomography Imaging of Sickle Cell Retinopathy Eyes Compared to Age- and Race-Matched Control Eyes
  78. Plasma Vascular Endothelial Growth Factor Concentrations after Intravitreous Anti–Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema
  79. Combining ODR and Blood Vessel Tracking for Artery–Vein Classification and Analysis in Color Fundus Images
  80. Comparison of Monthly vs Treat-and-Extend Regimens for Individuals With Macular Edema Who Respond Well to Anti–Vascular Endothelial Growth Factor Medications
  81. Automated classification and quantitative analysis of arterial and venous vessels in fundus images
  82. Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis
  83. Retinal Oximetry and Vessel Diameter Measurements With a Commercially Available Scanning Laser Ophthalmoscope in Diabetic Retinopathy
  84. Cholesterol Crystals Secondary to Coats-Like Response With Retinitis Pigmentosa
  85. Macula Society Collaborative Retrospective Study of Ocriplasmin for Symptomatic Vitreomacular Adhesion
  86. Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis
  87. YAG Laser Vitreolysis—Is It as Clear as It Seems?
  88. Computer-aided classification of sickle cell retinopathy using quantitative features in optical coherence tomography angiography
  89. Acute Vision Loss and Bilateral Macular Lesions
  90. Method for quantitative assessment of retinal vessel tortuosity in optical coherence tomography angiography applied to sickle cell retinopathy
  91. Profound Macular Ischemia on Optical Coherence Tomography Angiography in Severe Diabetic Retinopathy
  92. Pupillary responses in non-proliferative diabetic retinopathy
  93. Quantitative characteristics of sickle cell retinopathy in optical coherence tomography angiography
  94. Headaches and Foggy Vision in a 21-Year-Old Woman
  95. The Effects of Diabetic Retinopathy Stage and Light Flicker on Inner Retinal Oxygen Extraction Fraction
  96. Alterations in Retinal Layer Thickness and Reflectance at Different Stages of Diabetic Retinopathy by En Face Optical Coherence Tomography
  97. Initiation of intravitreal aflibercept injection treatment in patients with diabetic macular edema: a review of VIVID-DME and VISTA-DME data
  98. Worldwide Argus II implantation: recommendations to optimize patient outcomes
  99. Dissociations of the Fluocinolone Acetonide Implant: The Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study
  100. Chronic Visual Disturbance in a Young Healthy Man
  101. Painful Red Eye in a Woman in Her 70s
  102. Cross-Sectional analysis of neurocognitive function, retinopathy, and retinal thinning by Spectral-Domain optical coherence tomography in sickle cell patients
  103. Enface Thickness Mapping and Reflectance Imaging of Retinal Layers in Diabetic Retinopathy
  104. Factors Predicting Visual Acuity Outcome in Intermediate, Posterior, and Panuveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial
  105. Outcome of Treatment of Uveitic Macular Edema
  106. Blurred Vision in a Woman Who Had Sphenoid Wing Meningioma
  107. Surgical outcomes of 25-gauge pars plana vitrectomy for diabetic tractional retinal detachment
  108. New Pigmented Lesion Over a Site of Tumor Treatment
  109. Inner and Outer Retinal Thickness Mapping of Nonproliferative Diabetic Retinopathy by Spectral-Domain Optical Coherence Tomography
  110. Subconjunctival Hemorrhages and Retinal Vascular Abnormalities
  111. Conjunctival microvascular haemodynamics in sickle cell retinopathy
  112. One year results of a phase 1 study of the safety and tolerability of combination therapy using sustained release intravitreal triamcinolone acetonide and ranibizumab for subfoveal neovascular AMD
  113. Sudden-Onset Paracentral Vision Loss
  114. Wavefront Error Correction with Adaptive Optics in Diabetic Retinopathy
  115. Optical Coherence Tomography Retinal Thickness and Volume Measurements in X-Linked Retinoschisis
  116. Collaborative Retrospective Macula Society Study of Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
  117. Cotton-Wool Spots and Retinal Hemorrhages
  118. Neural Constraints on Visual Acuity in Proliferative Diabetic Retinopathy
  119. A Method for En Face OCT Imaging of Subretinal Fluid in Age-Related Macular Degeneration
  120. INTRAVITREAL ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR FOR CHOROIDAL NEOVASCULARIZATION IN OCULAR HISTOPLASMOSIS
  121. Smudge in My Vision
  122. Human bulbar conjunctival hemodynamics in hemoglobin SS and SC disease
  123. Rapid response of retinal pigment epithelial detachments to intravitreal aflibercept in neovascular age-related macular degeneration refractory to bevacizumab and ranibizumab
  124. Peripapillary Retinal Nerve Fiber Layer Thickness in Sickle-Cell Hemoglobinopathies Using Spectral-Domain Optical Coherence Tomography
  125. MULTIFOCAL RETINAL ASTROCYTIC HAMARTOMAS
  126. Age-Related Macular Degeneration
  127. Ophthalmic manifestations of sickle cell disease
  128. EN FACE SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY OUTER RETINAL ANALYSIS AND RELATION TO VISUAL ACUITY
  129. Object Frequency Characteristics of Visual Acuity
  130. Reply
  131. Feasibility of a Method for En Face Imaging of Photoreceptor Cell Integrity
  132. Structural and Functional Correlation in Sickle Cell Retinopathy Using Spectral-Domain Optical Coherence Tomography and Scanning Laser Ophthalmoscope Microperimetry
  133. Sustained-Release Intravitreal Liquid Drug Delivery Using Triamcinolone Acetonide for Cystoid Macular Edema in Retinal Vein Occlusion
  134. Central Macular Splaying and Outer Retinal Thinning in Asymptomatic Sickle Cell Patients by Spectral-Domain Optical Coherence Tomography
  135. Two-Year Outcomes of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study
  136. A COMPARISON OF HYPOXIA-INDUCIBLE FACTOR-α IN SURGICALLY EXCISED NEOVASCULAR MEMBRANES OF PATIENTS WITH DIABETES COMPARED WITH IDIOPATHIC EPIRETINAL MEMBRANES IN NONDIABETIC PATIENTS
  137. Chronic Coccidioidomycosis Endophthalmitis without Concomitant Systemic Involvement: A Clinicopathological Case Report
  138. REGRESSION OF CHOROIDAL NEOVASCULARIZATION AFTER VITRECTOMY FOR POSTINJECTION ENDOPHTHALMITIS
  139. Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study
  140. Prophylactic Treatment of Age-Related Macular Degeneration Report Number 2: 810-Nanometer Laser to Eyes With Drusen: Bilaterally Eligible Patients
  141. Reply
  142. Update on Laser Treatment of Diabetic Macular Edema
  143. Pharmacotherapy of age-related macular degeneration
  144. A Pilot Study of Fourier-Domain Optical Coherence Tomography of Retinal Dystrophy Patients
  145. Optical coherence tomography findings in paraneoplastic pseudovitelliform lesions in melanoma-associated retinopathy
  146. Primary transpupillary thermotherapy for small choroidal melanomas
  147. Presumed ocular tuberculosis presenting as a branch retinal vein occlusion in the absence of retinal vasculitis or uveitis
  148. Early onset vitreous amyloidosis in familial amyloidotic polyneuropathy with a transthyretin Glu54Gly mutation is associated with elevated vitreous VEGF
  149. Xanthogranuloma of the Iris Simulating Melanoma in an Adult
  150. New treatments for neovascular acute macular degeneration
  151. Pharmacotherapy for neovascular age-related macular degeneration: clinical trials and the art of medicine
  152. MACULAR DEGENERATION: THE LATEST IN CURRENT MEDICAL MANAGEMENT
  153. GROUP B STREPTOCOCCAL ENDOGENOUS ENDOPHTHALMITIS IN A NEONATE
  154. Prophylactic Treatment of Age-Related Macular Degeneration Report Number 1: 810-Nanometer Laser to Eyes with Drusen. Unilaterally Eligible Patients
  155. Photodynamic Therapy for Choroidal Neovascularisation Secondary to Inflammatory Chorioretinal Disease
  156. ONE-YEAR RESULTS OF A PILOT STUDY USING ORAL 13-CIS RETINOIC ACID AS A TREATMENT FOR SUBFOVEAL PREDOMINANTLY OCCULT CHOROIDAL NEOVASCULARIZATION IN PATIENTS WITH AGE-RELATED MACULAR DEGENERATION
  157. Hastening Choroidal Neovascularization: The Irony of Prophylactic Laser in Unilateral Eyes With High-Risk Drusen
  158. Sequential induction of angiogenic growth factors by TNF-α in choroidal endothelial cells
  159. Neuropilin-1 Expression by Endothelial Cells and Retinal Pigment Epithelial Cells in Choroidal Neovascular Membranes
  160. NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: ROUNDTABLE
  161. SCOTOMAS OF AGE-RELATED MACULAR DEGENERATION DETECTED AND CHARACTERIZED BY MEANS OF A NOVEL THREE-DIMENSIONAL COMPUTER-AUTOMATED VISUAL FIELD TEST
  162. Atypical Presentation of Multiple Evanescent White Dot Syndrome Involving Granular Lesions of Varying Size
  163. Outcomes of 140 Consecutive Cases of 25-Gauge Transconjunctival Surgery for Posterior Segment Disease
  164. Bartonella henselae infection presenting as a unilateral panuveitis simulating Vogt-Koyanagi-Harada syndrome
  165. Accumulation of NH2-Terminal Fragment of Connective Tissue Growth Factor in the Vitreous of Patients With Proliferative Diabetic Retinopathy
  166. Posterior uveal effusion syndrome after trabeculectomy in an eye with ocular venous congestion
  167. Diagnostic and Therapeutic Challenges
  168. Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia
  169. Episcleral plaque 125I radiotherapy with episcleral LCF hyperthermia: A prospective randomized trial
  170. Indocyanine green angiography in chorioretinal diseases: indications and interpretation
  171. Diabetic macular edema: review and update
  172. Macular disease
  173. Photodynamic therapy for choroidal neovascular disease: photosensitizers and clinical trials
  174. Update on pseudophakic cystoid macular edema treatment options
  175. Uveal metastasis 43 years after resection of bronchogenic carcinoid
  176. COMPARISON OF NONMYDRIATIC DIGITIZED VIDEO FUNDUS IMAGES WITH STANDARD 35-MM SLIDES TO SCREEN FOR AND IDENTIFY SPECIFIC LESIONS OF AGE-RELATED MACULAR DEGENERATION
  177. Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy
  178. A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation With Vitamins C and E, Beta Carotene, and Zinc for Age-Related Macular Degeneration and Vision Loss
  179. A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation With Vitamins C and E and Beta Carotene for Age-Related Cataract and Vision Loss
  180. Vitrectomy and membrane dissection surger: Author reply
  181. Exudative retinal detachment in relapsing polychondritis
  182. PARS PLANA VITRECTOMY FOR EPIRETINAL MEMBRANE SECONDARY TO CAT SCRATCH NEURORETINITIS
  183. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization—verteporfin in photodynamic th...
  184. Radioactive plaque therapy for metastatic choroidal carcinoma
  185. Submacular surgery trials randomized pilot trial of laser photocoagulation versus surgery for recurrent choroidal neovascularization secondary to age-related macular degeneration: i. ophthalmic outcomes submacular surgery trials pilot study report numb...
  186. Vitreoretinal surgery through multifocal intraocular lenses compared with monofocal intraocular lenses in fluid-filled and air-filled rabbit eyes
  187. A comparison of digital nonmydriatic fundus imaging with standard 35-millimeter slides for diabetic retinopathy
  188. Retina Vitreous-Macula
  189. Iatrogenic Choroidal Neovascularization
  190. Multiple evanescent white dot syndrome in older patients
  191. PARANEOPLASTIC RETINAL SYNDROMES
  192. Visual and anatomic outcomes associated with posterior segment complications after ganciclovir implant procedures in patients with AIDS and cytomegalovirus retinitis
  193. Macular Hole Surgery Using Thrombin-Activated Fibrinogen and Selective Removal of the Internal Limiting Membrane
  194. MACULAR HOLE SURGERY USING THROMBIN-ACTIVATED FIBRINOGEN AND SELECTIVE REMOVAL OF THE INTERNAL LIMITING MEMBRANE
  195. Histopathologic characteristics of uveal melanomas in eyes enucleated from the collaborative ocular melanoma study COMS report no. 6
  196. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma I: characteristics of patients enrolled and not enrolled COMS report no. 9
  197. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma II: initial mortality findings COMS report no. 10
  198. SYMPTOMATIC AGE-RELATED MACULAR DEGENERATION IN ASIAN PATIENTS
  199. Hydrogel Exoplant Fragmentation 10 Years After Scleral Buckling Surgery
  200. Indocyanine Green Angiography-guided Photocoagulation of Choroidal Neovascularization Associated With Retinal Pigment Epithelial Detachment
  201. Ultrapower surgical drill system evaluation
  202. Microbiologic Factors and Visual Outcome in the Endophthalmitis Vitrectomy Study
  203. Retained Lens Material Masquerading as a Growing, Pigmented Iris Tumor
  204. Ciliary Body Endophotocoagulation during Pars Plana Vitrectomy in Eyes with Vitreoretinal Disorders and Concomitant Uncontrolled Glaucoma
  205. Recent developments in indocyanine green angiography
  206. Postoperative Hypopyon After Intravitreal Bovine Thrombin for Macular Hole Surgery
  207. Anaphylactic Shock Following Indocyanine Green Angiography
  208. CLINICOPATHOLOGIC FEATURES OF INDOCYANINE GREEN ANGIOGRAPHY-IMAGED, SURGICALLY EXCISED CHOROIDAL NEOVASCULAR MEMBRANES
  209. RETINOBLASTOMA RECURRENCE AFTER IODINE 125 PLAQUE APPLICATION
  210. Submacular Hemorrhage Removal
  211. Selective Use of Indocyanine Green Angiography for Occult Choroidal Neovascularization
  212. Correspondence
  213. Indocyanine Green Angiography
  214. Subretinal Hemorrhage
  215. The Role of Gravity in Gentamicin-Induced Toxic Effects in a Rabbit Model
  216. Candidal Retinitis in a Gynecologic Patient
  217. Pilot Trial of Transscleral Diode Laser Retinopexy in Retinal Detachment Surgery-Reply
  218. Improved Visual Results after Surgical Repair of Cytomegalovirus-related Retinal Detachments
  219. ADENOMA OF THE NONPIGMENTED CILIARY EPITHELIUM
  220. Aminoglycoside Toxicity in the Treatment of Endophthalmitis
  221. Foveomacular Dystrophy
  222. A New Syndrome of Myelinated Nerve Fibers, Vitreoretinopathy, and Skeletal Malformations
  223. Laser Treatment of Choroidal Neovascularization in Patients With Angioid Streaks
  224. Pilot Trial of Transscleral Diode Laser Retinopexy in Retinal Detachment Surgery
  225. Intraocular Tissue Plasminogen Activator Concentrations after Subconjunctival Delivery
  226. VISUAL ABNORMALITIES ASSOCIATED WITH HIGH-ENERGY MICROWAVE EXPOSURE
  227. Late-onset Sterile Endophthalmitis After Molteno Tube Implantation
  228. Successful Treatment of Gram-negative Endophthalmitis With Intravitreous Ceftazidime
  229. ATYPICAL PARAFOVEAL TELANGIECTASIS WITH SUBSEQUENT ANTERIOR AND POSTERIOR SEGMENT NEOVASCULARIZATION
  230. Macular Hole Formation Following Laser Photocoagulation of Choroidal Neovascular Membranes in a Patient With Presumed Ocular Histoplasmosis
  231. What to tell the patient with optic neuritis about multiple sclerosis
  232. Intraocular Penetration of Topical Tissue Plasminogen Activator
  233. Anterior Granulomatous Uveitis in Patients with Multiple Sclerosis
  234. Brown-McLean Syndrome
  235. Penetrating Ocular Injury From Contaminated Eating Utensils
  236. A Retinal Pigment Epithelium Tear in a Patient With Angioid Streaks
  237. Assessment of Intraocular Pressure in Vitrectomized Gas-Containing Eyes
  238. Retinal Pigment Epithelium Tear in a Diabetic Patient With Exudative Retinal Detachment Following Panretinal Photocoagulation and Filtration Surgery
  239. Idiopathic Sclerochoroidal Calcification
  240. Comparison of the Challenger Digital Applanation Tonometer and the Goldmann Applanation Tonometer
  241. Ultraviolet light absorbing pseudophakos